Survival Prediction of Brain Cancer with Incomplete Radiology, Pathology, Genomic, and Demographic Data

Integrating cross-department multi-modal data (e.g., radiology, pathology, genomic, and demographic data) is ubiquitous in brain cancer diagnosis and survival prediction. To date, such an integration is typically conducted by human physicians (and panels of experts), which can be subjective and semi-quantitative. Recent advances in multi-modal deep learning, however, have opened a door to leverage such a process in a more objective and quantitative manner. Unfortunately, the prior arts of using four modalities on brain cancer survival prediction are limited by a “complete modalities” setting (i.e., with all modalities available). Thus, there are still open questions on how to effectively predict brain cancer survival from incomplete radiology, pathology, genomic, and demographic data (e.g., one or more modalities might not be collected for a patient). For instance, should we use both complete and incomplete data, and more importantly, how do we use such data? To answer the preceding questions, we generalize the multi-modal learning on cross-department multi-modal data to a missing data setting. Our contribution is three-fold: 1) We introduce a multi-modal learning with missing data (MMD) pipeline with competitive performance and less hardware consumption; 2) We extend multi-modal learning on radiology, pathology, genomic, and demographic data into missing data scenarios; 3) A large-scale public dataset (with 962 patients) is collected to systematically evaluate glioma tumor survival prediction using four modalities. The proposed method improved the C-index of survival prediction from 0.7624 to 0.8053.